(NP (NP (NN Objective)) (: :) (S (VP (NNP Predict) (NP (NP (NP (JJ individual) (JJ septic) (NNS children) (POS 's)) (VBN personalized) (NN physiologic) (NNS responses)) (PP (TO to) (NP (JJ vasoactive) (NNS titrations)))) (PP (IN by) (S (VP (VBG training) (NP (NP (DT a) (NNP Recurrent) (NNP Neural) (NNP Network)) (PRN (-LRB- -LRB-) (NP (NNP RNN)) (-RRB- -RRB-))) (S (VP (VBG using) (NP (NNP EMR) (NNS data))))))))) (. .))
(NP (NP (NNS Materials) (CC and) (NNS Methods)) (: :) (S (NP (DT This) (NN study)) (VP (ADVP (RB retrospectively)) (VBD analyzed) (NP (NP (NNP EMR)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN admitted) (PP (TO to) (NP (DT a) (JJ pediatric) (NN ICU)))))) (PP (PP (IN from) (NP (CD 2009))) (PP (TO to) (NP (CD 2017))))))) (. .))
(S (NP (NNP Data)) (VP (VBD included) (NP (NP (JJ charted) (NN time) (NN series) (NNS vitals)) (, ,) (NP (NNS labs)) (, ,) (NP (NNS drugs)) (, ,) (CC and) (NP (NP (NNS interventions)) (PP (IN of) (NP (NP (NNS children)) (PP (IN with) (NP (JJ septic) (NN shock))) (VP (VBD treated) (PP (IN with) (NP (NN dopamine) (, ,) (NN epinephrine) (, ,) (CC or) (NN norepinephrine))))))))) (. .))
(S (NP (DT A) (NNP RNN)) (VP (VBD was) (VP (VP (VBN trained) (S (VP (TO to) (VP (VB predict) (NP (NP (NNS responses)) (PP (IN in) (NP (NP (NP (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP SBP)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ diastolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP DBP)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MAP)) (-RRB- -RRB-)))))) (PP (TO to) (NP (CD 8,640) (NNS titrations))) (PP (IN during) (NP (CD 652) (JJ septic) (NNS episodes))))))) (CC and) (VP (VBN evaluated) (PP (IN on) (NP (NP (DT a) (NN holdout) (NN set)) (PP (IN of) (NP (CD 3,883) (NNS titrations))) (PP (IN during) (NP (CD 254) (NNS episodes)))))))) (. .))
(S (NP (NP (DT A) (JJ linear) (NN regression) (NN model)) (VP (VBG using) (NP (NN titration) (NNS data)) (PP (IN as) (NP (PRP$ its) (NN sole) (NN input))))) (VP (VBD was) (ADVP (RB also)) (VP (VP (VBN developed)) (CC and) (VP (VBN compared) (PP (TO to) (NP (DT the) (NNP RNN) (NN model)))))) (. .))
(S (NP (NN Evaluation) (NNS methods)) (VP (VBD included) (NP (NP (NP (DT the) (NN correlation) (NN coefficient)) (PP (IN between) (NP (NP (JJ actual) (NN physiologic) (NNS responses)) (CC and) (NP (NNP RNN) (NNS predictions))))) (, ,) (NP (NP (JJ mean) (NN absolute) (NN error)) (PRN (-LRB- -LRB-) (NP (NNP MAE)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN area)) (PP (IN under) (NP (DT the) (NN receiver) (VBG operating) (JJ characteristic) (NN curve))) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (DT The) (JJ actual) (NN physiologic) (NNS responses)) (VP (VP (VBD displayed) (NP (JJ significant) (NN variability))) (CC and) (VP (VBD were) (VP (VP (ADVP (RBR more) (RB accurately)) (VBN predicted) (PP (IN by) (NP (DT the) (NNP RNN) (NN model))) (PP (IN than) (PP (IN by) (NP (NP (NN titration)) (ADVP (RB alone)))))) (PRN (-LRB- -LRB-) (NP (NP (JJ r=0.20)) (NN vs) (NP (NN r=0.05))) (, ,) (NP (NN p) (NNP <) (CD 0.01)) (-RRB- -RRB-)))))) (. .))
(S (NP (DT The) (NNP RNN)) (VP (VBD showed) (NP (NP (NNP MAE) (CC and) (NNP AUC) (NNS improvements)) (PP (IN over) (NP (DT the) (JJ linear) (NN model))))) (. .))
(S (NP (NP (NP (DT The) (NNP RNN) (POS 's)) (NNP MAEs)) (VP (VBD associated) (PP (IN with) (NP (NN dopamine) (CC and) (NN epinephrine))))) (VP (VBD were) (ADJP (ADJP (NP (CD 1-3) (NN %)) (JJR lower)) (PP (IN than) (NP (NP (DT the) (JJ linear) (NN regression) (NN model) (NNP MAE)) (PP (IN for) (NP (NNP HR) (, ,) (NNP SBP) (, ,) (NNP DBP) (, ,) (CC and) (NNP MAP))))))) (. .))
(S (PP (IN Across) (NP (DT all) (NNS vitals) (NNS vasoactives))) (, ,) (NP (DT the) (NNP RNN)) (VP (VBD achieved) (NP (NP (ADJP (CD 1-19) (NN %)) (NNP AUC) (NN improvement)) (PP (IN over) (NP (DT the) (JJ linear) (NN model))))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (NP (NP (DT This) (JJ initial) (NN attempt)) (PP (IN in) (NP (JJ pediatric) (JJ critical) (NN care))) (S (VP (TO to) (VP (VB predict) (NP (NP (JJ individual) (NN physiologic) (NNS responses)) (PP (TO to) (NP (VB vasoactive) (JJ dose) (NNS changes))) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (JJ septic) (NN shock)))))))))) (VP (VBD demonstrated) (SBAR (S (NP (DT an) (NNP RNN) (NN model)) (VP (VBD showed) (NP (NP (DT some) (NN improvement)) (PP (IN over) (NP (DT a) (JJ linear) (NN model))))))))) (. .))
(S (SBAR (IN While) (S (ADVP (RB not) (RB yet)) (ADJP (RB clinically) (JJ applicable)))) (, ,) (NP (JJ further) (NN development)) (VP (MD may) (VP (VB assist) (NP (NP (JJ clinical) (NN administration)) (PP (IN of) (NP (JJ vasoactive) (NNS medications))) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (JJ septic) (NN shock)))))))) (. .))
